Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Noninvasive Coronary Imaging

02.09.2003


ESC Congress 2003: Picture Perfect – Progress in non-invasive imaging



There has been increasing awareness of the importance of composition of athero-thrombotic plaque as a major risk factor for acute coronary syndromes. Several invasive and noninvasive imaging techniques are available to assess athero-thrombotic vessels.

Most of the standard techniques identify luminal diameter or stenosis, wall thickness, or plaque volume (such as multi-slice CT, angiography, IVUS, etc.); however, none are effective in determining the plaques that are unstable and vulnerable to thrombosis and proliferation. In vivo, high-resolution, multi-contrast, magnetic resonance imaging (MRI) holds the best promise of non-invasively imaging vulnerable plaques and determination of the different plaque components such as lipid core, fibrosis, calcifications and thrombosis deposits in all arteries including the coronary arteries.


The MR findings have been extensively validated against pathology in ex vivo studies of carotid, aortic, and coronary artery specimens obtained at autopsy. Subsequent work on imaging carotid arteries in vivo in patients referred for endarterectomy showed a high correlation with pathology and with previous ex vivo results.

A recent study in patients with plaques in the thoracic aorta showed that when compared to transesophageal echocardiography, plaque composition and size are accurately characterized and measured using in vivo MRI. Carotid and aortic athero-thrombotic plaque assessment by MRI may lend itself to use as a screening tool for prediction of future cardiovascular events and for the evaluation of therapeutic intervention benefits.

These MR techniques have been also adapted for the study of plaques in different animal models. Therefore, MRI can be used as an investigative to follow in vivo progression, regression and plaque stabilization in different transgenic and non-transgenic animal models.

The ultimate goal is imaging of plaque in vivo in human coronary arteries. Preliminary studies in a porcine model of athero-thrombosis showed that the major difficulties of MR coronary wall imaging are due to the combination of cardiac and respiratory motion artifacts, the non-linear course of the coronary arteries, as well as their relatively small size and location.

Studies in an in-vivo pig model and in humans suggest that MRI may soon be applicable to study and characterize athero-thrombotic plaques in human coronaries in vivo. We have shown recently the utility of MRI in the study of treatment in humans. MR was used to measure the effect of lipid-lowering therapy (statins) in asymptomatic untreated hypercholesterolemic patients with carotid and aortic atherosclerosis.

In conclusion, the assessment of athero-thrombotic plaques by imaging techniques is essential for the identification of vulnerable plaques. In vivo, high-resolution, multi-contrast, MRI holds the best promise of non-invasively imaging vulnerable plaques and characterizing the different components in all arteries including the coronary arteries. MR allows serial evaluation assessment of the progression and regression of atherosclerosis over time. The use of specific MR contrast agents targeted for athero-thrombotic plaque imaging may enhance the plaque characterization. Application of MRI opens new areas for diagnosis, prevention, and treatment (e.g., lipid-lowering drug regimens) of athero-thrombosis in all arterial locations.

Roberto Corti, MD
Cardiology, University Hospital Zurich
Switzerland

Important: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology


Camilla Dormer | alfa
Further information:
http://www.escardio.org

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>